The Swiss Neuromodulation Society
The Swiss Neuromodulation Society is the duly recognized national chapter society of the International Neuromodulation Society (INS). It is a non-profit organisation founded in 2010 and devoted to the advancement of the field of neuromodulation in Switzerland. It is composed of clinicians and scientists working in all aspects of neuromodulation including anesthesiology,...
Home Page
Join us !
By joining the Swiss Neuromodualtion Society, you will benefit from :
Free subscription to Neuromodulation: Technology at the Neural Interface, the International Neuromodulation Society's bi-monthly journal and online access to back issues;
Simultaneous membership to the International Neuromodulation Society at no extra-cost;
Unlimited access to the SNS and INS interactive...
The Swiss Neuromodulation Society organises every year since 2011 its yearly scientific congress. The 2011, 2012 and 2013 editions were joint meetings with the Swiss Society for Interventional Pain Management (SSIPM) and were hold in Montreux with internationally reknown speakers.
2013 SNS Congress (programme... +
In the bylaws established by the Swiss Neuromodulation Society (SNS), the Society gives itself the objective to promote study, progress, teaching, and diffusion of Neuromodulation. In this view, the Society organizes scientific meetings. The promotion of scientific multicentric studies becomes an important objective for the Scientific Committee.... +
The Swiss Neuromodulation Society is currently working on a project of a national database in collaboration with Dr Kaare Meier from the University of Aarhus in Dennmark. The database will be made freely available to centers performing neuromodulation implants in Switzerland. It will enable the introduction of data on spinal cord stimulator and... +
Treatments of non-professional diseases are covered by health insurances, provided that the treatment is listed in the catalog of mandatory insurance benefits (LAMal). Accidents and Professional Diseases are in turn supported by the accident insurance and are regulated by the LAA.
For non-professional diseases, the reimbursement of a medical... +
Thursday, July 17, 2014:
For the first time ever, a paralysed man has moved his fingers and hand with his own thoughts after an electronic neural bypass for spinal cord injuries that reconnects the brain directly to muscles, allowing voluntary and functional control of a paralysed limb. This innovation comes from a partnership between The Ohio State University Wexner Medical Center and Battelle.
Ian Burkhart, a 23-year-old quadriplegic from Dublin, USA, is the...
Saturday, March 29, 2014: The US Food and Drug Administration (FDA) has approved marketing of Cefaly, the first device as a preventative treatment for migraine. This is also the first transcutaneous electrical nerve stimulation (TENS) device specifically authorised for use prior to the onset of pain.
“Cefaly provides an alternative to medication for migraine prevention,” says Christy Foreman, director of the Office of Device Evaluation at the FDA’s...
Saturday, March 29, 2014: Burst technology expands treatment options for patients suffering from chronic pain and provides significant relief so they can reclaim their quality of life,” says Dirk De Ridder, neurological professor of Neurosurgery, from the University of Otago in Dunedin, New Zealand. “Prodigy’s pioneering stimulation mode allows me to tune therapy to my patient’s unique pain condition. Burst holds promise to fill the void where...
Sunday, October 27, 2013: Stimulating a set of neurons deep in the brain has allowed rats with severe spinal cord injuries to walk almost normally again, a group of Swiss researchers reports in Science Translational Medicine this week. The rats were not completely paralyzed, but had damage to 70 to 80 percent of their reticulospinal fibers, so they had previously walked with greatly impaired strength and speed. In animals with paralyzed back legs, the technique didn'...
Sunday, October 27, 2013: The next INS Expert Panel discussion will focus on the subject of percutaneous vs. paddle leads for spinal cord stimulation. From 27 Oct. to 10 Nov., INS President Dr. Simon Thomson and Director-at-Large Dr. Konstantin Slavin will lead a discussion comparing minimally invasively placed cylindrical leads and neurosurgically placed laminectomy-type electrodes.
The topic was selected based on a publication by INS member Dr. Nandan Lad and co-...
Saturday, October 5, 2013: From 8-22 October, the International Neuromodulation Society is hosting an online discussion about repetitive transcranial magnetic stimulation for neuropathic pain, moderated by Prof. Turo Nurmikko, MD, PhD, professor in Pain Relief, The Walton Centre NHS Foundation Trust, and director of the Pain Research Institute. Prof. Nurmikko leads several research projects involving the peripheral and central mechanisms of chronic and experimental pain,...
Friday, September 6, 2013: Several health insurers have recently refused to reimburse the controls of neurostimulator and pump refillings if these exceeded 20 minutes (more than 4 times the 29.2000 position ). An application was filed with the PIK/CPI (Tarmed). The latter confirms that the only limitation is 60 times during 6 months, regardless of the number of sessions. Controls of neurostimulator and pumps refillings can now be charged according to the actual...
